# Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering

> **NCT06612996** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Al-Azhar University** · enrollment: 180 (estimated)

## Conditions studied

- Lower Extremity Chronic Venous Ulcers
- Varicose Veins Leg
- Hernia

## Interventions

- **DRUG:** Tramadol
- **DRUG:** Magnesium sulphate
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT06612996
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-10
- **Primary completion:** 2025-01-10
- **Final completion:** 2025-01-10
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06612996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06612996, "Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06612996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*